Target intelligence / Profile preview

Glucan-binding protein (Streptococcus mutans) (GBP)

Target
GBP
Molecular classification
Bacterial surface protein, Glucan-binding protein, Adhesin
01

Overview

Glucan-binding proteins (GBPs) of Streptococcus mutans are a family of cell-surface and secreted proteins that serve as receptors for glucan polymers, which are synthesized from sucrose by glucosyltransferases (Banas, 2003). These proteins, including GbpA, GbpB, GbpC, and GbpD, are fundamental to the virulence of S. mutans as they mediate the sucrose-dependent adhesion and aggregation of bacteria on the tooth surface (Lynch et al., 2015). This process leads to the development of a complex biofilm known as dental plaque, where bacterial fermentation of carbohydrates produces organic acids that demineralize tooth enamel, resulting in dental caries (Mattos-Graner et al., 2001). GbpB is particularly notable as it is essential for cell wall integrity and has been identified as a primary target for the development of dental vaccines aimed at inducing protective mucosal IgA responses (Smith, 2002). Therapeutic strategies targeting GBPs focus on disrupting the molecular interactions between the bacteria and the glucan matrix to prevent biofilm maturation and subsequent tooth decay. Experimental approaches include the use of subunit vaccines and small-molecule inhibitors designed to block the glucan-binding domains of these proteins.

Other names
GBPGbpAGbpBGbpCGbpDGlucan-binding protein receptorGlucan-binding protein
02

Mechanism of action

Inhibition of bacterial adhesion and biofilm formation by blocking the interaction between the protein and glucan polymers.

03

Biological functions

Biofilm formationCell adhesionCarbohydrate bindingCell wall organizationBacterial aggregation
04

Disease associations

Dental cariesInfectionBiofilm-related diseases
05

Safety considerations

Potential for oral microbiome dysbiosisImmunological cross-reactivity with human tissue (theoretical)Development of bacterial resistance to inhibitors
06

Interacting drugs

Experimental GbpB-based vaccines

2 more in the full profile.

07

Biomarkers

Salivary anti-GbpB IgA antibody titersStreptococcus mutans colony-forming units (CFU) in dental plaqueGlucan-binding protein expression levels

Beyond the preview

Go deeper on Glucan-binding protein (Streptococcus mutans) (GBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucan-binding protein (Streptococcus mutans) (GBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call